A new triphenylethylene compound, Fc-1157a Sinikka KallioLauri KangasReijo Toivola Original Articles Pages: 103 - 108
A new triphenylethylene compound, Fc-1157a Lauri KangasAnna-Liisa NieminenReijo Toivola Original Articles Pages: 109 - 113
Enhanced therapeutic effect of methotrexate in experimental rat leukemia after inactivation of cobalamin (vitamin B12) by nitrous oxide A. C. M. KroesJ. LindemansJ. Abels Original Articles Pages: 114 - 120
Distribution and tumor penetration properties of a radiosensitizer 2-[14C] misonidazole (Ro 07-0582), in mice and rats as studied by whole-body autoradiography G. AkelP. BenardG. Soula Original Articles Pages: 121 - 126
Loss of viability and induction of DNA damage in human leukemic myeloblasts and lymphocytes by m-AMSA L. W. BroxA. BelchE. Pollock Original Articles Pages: 127 - 132
Pharmacokinetics and plasma protein binding of two platinum cytostatics CHIP and CBDCA in rats A. LázníčkováM. LázníčekJ. Drobník Original Articles Pages: 133 - 136
Therapeutic response to taxol of six human tumors xenografted into nude mice J. RiondelM. JacrotP. Potier Original Articles Pages: 137 - 142
Clinical pharmacology of 4-demethoxydaunorubicin (DMDR) Katherine LuNiramol SavarajTi Li Loo Original Articles Pages: 143 - 148
The clinical pharmacology of mitozantrone John F. SmythJanet S. MacphersonC. Roland Wolf Original Articles Pages: 149 - 152
Serum and tissue concentrations of doxorubicin after IV administration of doxorubicin or doxorubicin-DNA complex to patients with gastrointestinal cancer Peter GunvénNils Olof TheveCurt Peterson Original Articles Pages: 153 - 156
Maintenance chemotherapy for anaplastic small cell carcinoma of the bronchus: A randomised, controlled trial Michael CullenDavid MorganMidlands Small Cell Lung Cancer Group Original Articles Pages: 157 - 160
Treatment of leukemia and myelodysplastic syndromes with orally administered N4-palmitoyl-l-β-D-arabinofuranosylcytosine Ryuzo OhnoMasami HiranoTokai Blood Cancer Study Group Original Articles Pages: 161 - 164
Adverse effect of cis-diamminedichloroplatinum II (CDDP) on porphyrin metabolism in man C. G. AlexopoulosG. ChalevelakisG. Pallikaris Original Articles Pages: 165 - 170
Methotrexate-vindesine association in head and neck cancer: modification of methotrexate's hydroxylation in presence of vindesine P. BoreN. LenaY. Carcassonne Original Articles Pages: 171 - 176
The influence of a graded dose schedule of aminoglutethimide on the disposition of the optical enantiomers of warfarin in patients with breast cancer P. E. LønningP. M. UelandS. Kvinnsland Original Articles Pages: 177 - 181
Serial serum AFP heterogeneity changes in patients with hepatocellular carcinoma during chemotherapy P. K. BuamahC. CornellA. L. Harris Original Articles Pages: 182 - 184
Renal function in the elimination of oral melphalan in patients with multiple myeloma C. G. AdairJ. M. BridgesZ. R. Desai Original Articles Pages: 185 - 188
Treatment of blastic transformation of chronic myelogenous leukemia with mitoxantrone Zalmen A. ArlinEllin BermanGary Dukart Original Articles Pages: 189 - 190
Acute and long-term nephrotoxicity of cis-platinum in man Steffen GrothH. NielsenM. Rørth Original Articles Pages: 191 - 196